Fulcrum Genomics
Private Company
Total funding raised: $57M
Overview
Fulcrum Genomics operates as a specialized bioinformatics consultancy and software development firm, serving a global clientele from single-person startups to large pharmaceutical and diagnostic companies. The company leverages a distributed team of world-class bioinformaticians, computational biologists, and software engineers to solve complex data analysis challenges, invent novel algorithms, and deliver high-quality, tailored software solutions. Unlike a traditional product-focused biotech, Fulcrum's business model is centered on providing high-value consulting services and custom tool development, positioning it as a critical enabler for innovation across the life sciences sector. Their deep expertise in understanding how biological molecules become data allows them to support technology development and drive insights for their clients' success.
Technology Platform
A service-based model leveraging a team of expert bioinformaticians and software engineers to build custom analysis tools, pipelines, and systems. Their platform is their collective expertise in translating molecular data into insights, applying and inventing algorithms tailored to client-specific biological questions.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Fulcrum competes in the bioinformatics services space against other boutique consulting firms, larger Contract Research Organizations (CROs) with bioinformatics divisions, and the in-house teams of its potential clients. Its key differentiator is a deep, dual expertise in biology and production-grade software engineering, appealing to clients needing innovative, custom solutions rather than generic analysis.